Profile
Norman Michael Greenberg is currently Director at Mongoose Bio, Inc. Former positions include Senior Director-Research at Pfizer Inc. from 2009 to 2011, Chief Scientific Officer at Atreca, Inc. from 2016 to 2021, Associate Professor at Baylor College of Medicine from 1998 to 2003, Member at Fred Hutchinson Cancer Research Center, Vice President-Global Research at MedImmune LLC from 2011 to 2014, Senior Vice President-Translational Medicine at Checkmate Pharmaceuticals, Inc. from 2015 to 2016, and President & Chief Executive Officer at NMG Scientific Consulting USA from 2014 to 2016.
Education includes a doctorate from the University of British Columbia and an undergraduate degree from the University of Toronto.
Norman Michael Greenberg active positions
| Companies | Position | Start |
|---|
Former positions of Norman Michael Greenberg
| Companies | Position | End |
|---|---|---|
| ATRECA, INC. | Chief Tech/Sci/R&D Officer | 2021-03-30 |
| CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2016-04-30 |
NMG Scientific Consulting USA | Chief Executive Officer | 2016-04-30 |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Chief Tech/Sci/R&D Officer | 2014-04-30 |
| PFIZER INC. | Chief Tech/Sci/R&D Officer | 2011-06-30 |
Training of Norman Michael Greenberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Atreca, Inc.
Atreca, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel antibody-based immune therapeutics to treat a range of solid tumor cancers | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Commercial Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
NMG Scientific Consulting USA |
- Stock Market
- Insiders
- Norman Michael Greenberg
















